The Development and Application of the Glucose Uptake Stimulating Cell Model

doi:10.7677/ynzwyj201515046

Plant Diversity ›› 2015, Vol. 37 ›› Issue (06): 821-827.DOI: 10.7677/ynzwyj201515046

• Articles • Previous Articles Next Articles

The Development and Application of the Glucose Uptake Stimulating Cell Model

HU Hai-Jun-1、3, TIAN Wei-Feng-1、3, LU Yan-Ting-1、3, LIU Hai-Yang-1, HU Jing-1, GONGPAN Pian-Chou-1、3, WANG Fang-1、3, ZHANG Yu-Mei-2**, XIONG Wen-Yong-1**, KONG Qing-Hua-1

1 State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy
of Sciences, Kunming 650201, China; 2 Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences,
Kunming 650223, China; 3 University of Chinese Academy of Sciences, Beijing 100049, China

Received:2015-03-16 Online:2015-11-25 Published:2015-06-23
Supported by:
中国科学院 (292013312D11004)；云南省科技厅 (39Y33H521261, 2014FA043) 基金资助

Abstract

Abstract:

The plants are great resources for digging leading compounds, and many current antidiabetic drugs are derived from plants. The key to discover compounds with antidiabetic activities from plants relies on the application of antidiabetic drug screening models. In order to establish a more stable and reliable antidiabetic drug screening model, we optimized the screening model based on the glucose uptake of adipocytes. In the previous models, insulin was used as the only positive control, while in our model both insulin and rosiglitazone were used as positive controls, which made the model more stable and reliable. Furthermore, we expanded the application of the model to screen the insulin signaling pathway inhibitors, and Akt1/2 inhibitor which was an inhibitor of insulin signaling pathway was used as positive control. In the end, we screened 16 compounds isolated from plants using this model and identified three active compounds with glucose uptake stimulating activities. We also performed the doseresponse experiments of compound X15 and X16. Both showed significant doseresponses. These activities were first reported at the cell level, providing fundamental data for their mechanisms study of the activities and for the potential development of the drugs in future.

Key words: 3T3-L1 adipocytes, Anti-diabetic drug screening, Cell model, Glucose uptake, Natural products

CLC Number:

Q 946

HU Hai-Jun-, TIAN Wei-Feng-, LU Yan-Ting-, LIU Hai-Yang-, HU Jing-, GONGPAN Pian-Chou-, WANG Fang-, ZHANG Yu-Mei-**, XIONG Wen-Yong-**, KONG Qing-Hua. The Development and Application of the Glucose Uptake Stimulating Cell Model[J]. Plant Diversity, 2015, 37(06): 821-827.

References

Alberti KG, Zimmet PZ, 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation［J］. Diabetic Medicine, 15: 539—553
Cheng AY, Fantus IG, 2005. Oral antihyperglycemic therapy for type 2 diabetes mellitus［J］. Canadian Medical Association Journal, 172: 213—226
Frost SC, Lane MD, 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulinactivated hexose transport by 3T3L1 adipocytes［J］. Journal of Biological Chemistry, 260: 2646—2652
Govers R, Coster ACF, James DE, 2004. Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway［J］. Molecular and Cellular Biology, 24: 6456—6466
Jin HG, Jin Q, Kim AR et al., 2012. A new triterpenoid from alisma orientale and their antibacterial effect［J］. Archives of Pharmacal Research, 35: 1919—1926
Leney SE, Tavaré JM, 2009. The molecular basis of insulinstimulated glucose uptake: signalling, trafficking and potential drug targets［J］. Journal of Endocrinology, 203: 1—18
Leto D, Saltiel AR, 2012. Regulation of glucose transport by insulin: traffic control of GLUT4［J］. Nature Reviews Molecular Cell Biology, 13: 383—396
Li JN (李晋南), Liu MY (刘铭瑶), Hou YT (侯玉婷) et al., 2009. Human fibroblast growth factor 21regulates glucose uptake in 3T3L1 adipocytes［J］. Chinese Journal of Biochemistry and Molecular Biology (中国生物化学与分子生物学学报), 25: 556—562
Li Q, Qu H, 2012. Study on the hypoglycemic activities and metabolism of alcohol extract of alismatis rhizoma［J］. Fitoterapia, 83: 1046—1053
Matsuda H, Li Y, Murakami T et al., 1998. Antidiabetic principles of natural medicines. III. structurerelated inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity［J］. Chemical & Pharmaceutical Bulletin, 46: 1399—1403
Mayerson AB, Hundal RS, Dufour S et al., 2002. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes［J］. Diabetes, 51: 797—802
Nathan DM, Buse JB, Davidson MB et al., 2009. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement of the american diabetes association and the european association for the study of diabetes［J］. Diabetes Care, 32: 193—203
Saltiel AR, Kahn CR, 2001. Insulin signalling and the regulation of glucose and lipid metabolism［J］. Nature, 414: 799—806
Smith JD, Clinard VB, 2014. Natural products for the management of type 2 diabetes mellitus and comorbid conditions［J］. Journal of the American Pharmacists Association, 54: e304—e321
Spiegelman B, 1998. PPARgamma: adipogenic regulator and thiazolidinedione receptor［J］. Diabetes, 47: 507—514
Vinik AI, Vinik E, 2003. Prevention of the complications of diabetes［J］. American Journal of Managed Care, 9: S63—S80
Weill J, Vanderbecken S, Froguel P, 2004. Understanding the rising incidence of type 2 diabetes in adolescence［J］. Archives of Disease in Childhood, 89: 502—504
Whiting DR, Guariguata L, Weil C et al., 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030［J］. Diabetes Research and Clinical Practice, 94: 311—321
Xie JQ (谢洁琼), 2005. The development and application of the methods of screening for the antidiabetic drugs［D］. Academy of Military Medical Sciences (中国人民解放军军事医学科学院)
Zhou L, Yang Y, Wang X et al., 2007. Berberine stimulates glucose transport through a mechanism distinct from insulin［J］. Metabolism, 56: 405—412

[1]	LI Shi-Fei^, , HUANG Nian-Xu , HAO Xiao-Jiang , LI Ling, LI Shun-Lin. Effect of Chemical Constituents from Syzygium cumini (Myrtaceae) on Glucose Uptake in Insulin-resistant L6 Cells [J]. Plant Diversity, 2009, 31(05): 469-473.
[2]	JIANG Li-Hua, TAN Ning-Hua, YANG Ya-Bin, WANG Jun-Song, FU Xiang Lars JOHANNSEN, Hartwing MUELLER, Thomas HENKEL. Seqarching for Antibacterial Activities of Extracts and Fractions Derived from Natural Sources Targeting Enoylpyruvate Transferase [J]. Plant Diversity, 2003, 25(01): 1-3.
[3]	JIA Rui -Rui,TAN Ning -Hua, MU Qing, LI Chao- Ming,QIU Ming-Hua,LIU Jik-Kai. The Effect of Some Natural Products on the Fibrinolytic System [J]. Plant Diversity, 2000, 22(04): 1-3.

The Development and Application of the Glucose Uptake Stimulating Cell Model

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics